DWTI announced "Notice regarding Initiation of Japan Phase IIb clinical trials of anti-platelet agent K-134 and receipt of milestone payment" (See IR Library for more details.)

DWTI announced "Notice regarding Japan Phase IIb clinical trials of anti-platelet agent K-134" (See IR Library for more details.)

DWTI announced "Notice regarding Japan Phase III clinical trial (combination therapy) of anti-glaucoma agent K-115" (See IR Library for more details.)

DWTI announced "Notice regarding announcement on Phase IIa clinical study results of anti-platelet agent K-134 in AHA 2011"

DWTI announced Financial results for the third quarter of Fiscal 2011.

DWTI announced "Notice regarding Issuance of Stock Acquisition Rights (“SARs”) through third-party allocation, and conclusion of third party allotment agreement with commitment clause".

DWTI announced “Notice regarding presentation on the synthesis of PET molecular probe at the World Molecular Imaging Congress (WMIC) 2011”

DWTI announced Financial results for the second quarter of Fiscal 2011.

DWTI announced "Notice regarding Japan Phase III clinical trials of anti-glaucoma agent K-115".

DWTI announced Financial results for the first quarter of Fiscal 2011.